MENU
HRMY
AS OF
Jan 14, 04:59 PM (EDT)
Price
$36.05
Change
+$0.29 (+0.81%)
Capitalization
2.08B
47 days until earnings call
Intraday BUY SELL Signals
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
HRMY
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Harmony Biosciences Holdings (HRMY) Ownership - Who owns Harmony Biosciences Holdings?

Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs... Show more

#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
N/A
Address
630 West Germantown Pike
Phone
+1 484 539-9800
Employees
246
Web
https://www.harmonybiosciences.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
2.08B
P/E Ratio
11.37
Total Cash
672.58M
Projected Growth
N/A
Total Debt
168.51M
Revenue
825.94M
Risk (Beta)
1.19
Dividend Yield
N/A
Total Cash/Share
11.68
Total Debt/Equity
N/A
Revenue/Share
14.09 USD as % of share price

Fundamentals

HRMY
Capitalization
2.08B
P/E Ratio
11.37
Risk (Beta)
1.19
Dividend Yield
N/A
Total Cash
673M
Total Cash/Share
11.68
Total Debt
169M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
14.09%
Revenue
826M
ROE
N/A
Book Value
835M
P/B Ratio
2.49
Cash Flow
N/A
Earnings
3.23
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
1K
Current Ratio
3.75
Current Revenue Per Employee
893488.80
Dividends Per Share - Security
N/A
EBITDA
270M
Float
N/A
Float - Current
N/A
Gross Income Margin
75.09
Revenue To Assets
17.38
Shares Held By Institutions
2.29B
Shares Outstanding - Current
57.6M
Total Liabilities
373M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-4.436
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
Swing Trader, Long Only with Inverse: Valuation Model for Energy Sector (TA&FA)Swing Trader, Long Only with Inverse: Valuation Model for Energy Sector (TA&FA)
Annualized Return+37%
VIEW DETAILSVIEW DETAILS
VIEW FOR FREEVIEW FOR FREE
HRMY
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. HRMY showed earnings on November 04, 2025. You can read more about the earnings report here.
View AI-Driven Trading for HRMY
A.I. Advisor
published General Information

General Information

a commercial-stage pharmaceutical company, which engages in the development and commercialization of therapies for the treatment of neurological disorders

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
630 West Germantown Pike
Phone
+1 484 539-9800
Employees
246
Web
https://www.harmonybiosciences.com